These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15027881)

  • 1. Structure-activity study of the ORL1 antagonist Ac-Arg-D-Cha-Qaa-D-Arg-D-p-ClPhe-NH2.
    Van Cauwenberghe S; Simonin F; Cluzeau J; Becker JA; Lubell WD; Tourwé D
    J Med Chem; 2004 Mar; 47(7):1864-7. PubMed ID: 15027881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing opioid receptor interactions with azacycloalkane amino acids. Synthesis of a potent and selective ORL1 antagonist.
    Halab L; Becker JA; Darula Z; Tourwé D; Kieffer BL; Simonin F; Lubell WD
    J Med Chem; 2002 Nov; 45(24):5353-7. PubMed ID: 12431062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist.
    Ozaki S; Kawamoto H; Itoh Y; Miyaji M; Azuma T; Ichikawa D; Nambu H; Iguchi T; Iwasawa Y; Ohta H
    Eur J Pharmacol; 2000 Aug; 402(1-2):45-53. PubMed ID: 10940356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationships of aminoalkylazetidines as ORL1 receptor ligands.
    Wu WL; Caplen MA; Domalski MS; Zhang H; Fawzi A; Burnett DA
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3157-60. PubMed ID: 12372523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a hexapeptide binding region in the nociceptin (ORL1) receptor by photo-affinity labelling with Ac-Arg-Bpa-Tyr-Arg-Trp-Arg-NH2.
    Bes B; Meunier JC
    Biochem Biophys Res Commun; 2003 Oct; 310(3):992-1001. PubMed ID: 14550303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UFP-101, a high affinity antagonist for the nociceptin/orphanin FQ receptor: radioligand and GTPgamma(35)S binding studies.
    McDonald J; Calo G; Guerrini R; Lambert DG
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):183-7. PubMed ID: 12595960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nociceptin activation of the human ORL1 receptor expressed in Chinese hamster ovary cells: functional homology with opioid receptors.
    Fawzi AB; Zhang H; Weig B; Hawes B; Graziano MP
    Eur J Pharmacol; 1997 Oct; 336(2-3):233-42. PubMed ID: 9384238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal modifications leading to peptide ORL1 partial agonists and antagonists.
    Judd AK; Kaushanskaya A; Tuttle DJ; Sanchez A; Khroyan T; Polgar W; Toll L
    J Pept Res; 2003 Nov; 62(5):191-8. PubMed ID: 14531842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid receptor-like 1 (ORL1) receptor binding and the biological properties of Ac-Arg-Tyr-Tyr-Arg-Ile-Arg-NH2 and its analogs.
    Ambo A; Kohara H; Kawano S; Sasaki Y
    J Pept Sci; 2007 Oct; 13(10):672-8. PubMed ID: 17712865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the G-protein-coupled ORL1 receptor in the mouse spinal cord by [35S]-GTPgammaS binding and immunohistochemistry.
    Narita M; Mizoguchi H; Oji DE; Dun NJ; Hwang BH; Nagase H; Tseng LF
    Br J Pharmacol; 1999 Nov; 128(6):1300-6. PubMed ID: 10578145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro inhibitory effects of J-113397 on nociceptin/orphanin FQ-stimulated.
    Ichikawa D; Ozaki S; Azuma T; Nambu H; Kawamoto H; Iwasawa Y; Takeshima H; Ohta H
    Neuroreport; 2001 Jun; 12(8):1757-61. PubMed ID: 11409754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of the novel radioligand [(3)H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptors.
    Ibba M; Kitayama M; McDonald J; Calo G; Guerrini R; Farkas J; Toth G; Lambert DG
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Dec; 378(6):553-61. PubMed ID: 18807245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligands for kappa-opioid and ORL1 receptors identified from a conformationally constrained peptide combinatorial library.
    Becker JA; Wallace A; Garzon A; Ingallinella P; Bianchi E; Cortese R; Simonin F; Kieffer BL; Pessi A
    J Biol Chem; 1999 Sep; 274(39):27513-22. PubMed ID: 10488086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural requirements of nociceptin antagonist Ac-RYYRIK-NH2 for receptor binding.
    Kawano C; Okada K; Honda T; Nose T; Sakaguchi K; Costa T; Shimohigashi Y
    J Pept Sci; 2002 Oct; 8(10):561-9. PubMed ID: 12450325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro binding and functional studies of Ac-RYYRIK-ol and its derivatives, novel partial agonists of the nociceptin/orphanin F/Q receptor.
    Gunduz O; Sipos F; Spagnolo B; Kocsis L; Magyar A; Orosz G; Borsodi A; Calò G; Benyhe S
    Neurosignals; 2006-2007; 15(2):91-101. PubMed ID: 16874009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-Activity Relationships of the Peptide Kappa Opioid Receptor Antagonist Zyklophin.
    Joshi AA; Murray TF; Aldrich JV
    J Med Chem; 2015 Nov; 58(22):8783-95. PubMed ID: 26491810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A structure-activity study of nociceptin-(1-13)-peptide amide. Synthesis of analogues substituted in positions 0, 1, 3, 4 and 10.
    Bobrova I; Vlaskovska M; Kasakov L; Surovoy A; Egorova N; Johansson L; Karsnas P; Terenius L
    Eur J Med Chem; 2003; 38(7-8):687-94. PubMed ID: 12932899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nociceptin antagonism: probing the receptor by N-acetyl oligopeptides.
    Kocsis L; Orosz G; Magyar A; Al-Khrasani M; Kató E; Rónai AZ; Bes B; Meunier JC; Gündüz O; Tóth G; Borsodi A; Benyhe S
    Regul Pept; 2004 Nov; 122(3):199-207. PubMed ID: 15491792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capturing of the free cysteine residue in the ligand-binding site by affinity labeling of the ORL1 nociceptin receptor.
    Matsushima A; Nishimura H; Inamine S; Uemura S; Shimohigashi Y
    Bioorg Med Chem; 2011 Dec; 19(24):7597-602. PubMed ID: 22061823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity studies on nociceptin analogues: ORL1 receptor binding and biological activity of cyclic disulfide-containing analogues of nociceptin peptides.
    Ambo A; Hamazaki N; Yamada Y; Nakata E; Sasaki Y
    J Med Chem; 2001 Nov; 44(23):4015-8. PubMed ID: 11689089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.